CVS Health Corp (NYSE: CVS) kicked off on Friday, up 0.52% from the previous trading day, before settling in for the closing price of $69.39. Over the past 52 weeks, CVS has traded in a range of $64.41-$83.25.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 13.36%. While this was happening, its average annual earnings per share was recorded -5.17%. With a float of $1.26 billion, this company’s outstanding shares have now reached $1.29 billion.
Considering the fact that the conglomerate employs 300000 people, you should pay attention to its efficiency factor.
CVS Health Corp (CVS) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Healthcare Plans Industry. The insider ownership of CVS Health Corp is 0.19%, while institutional ownership is 82.23%. The most recent insider transaction that took place on Feb 16 ’24, was worth 2,267,947. In this transaction EVP and Pres-Pharm, Consumer W of this company sold 29,473 shares at a rate of $76.95, taking the stock ownership to the 39,765 shares. Before that another transaction happened on Nov 03 ’23, when Company’s Director bought 2,000 for $70.47, making the entire transaction worth $140,930. This insider now owns 20,630 shares in total.
CVS Health Corp (CVS) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 69.75 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -5.17% per share during the next fiscal year.
CVS Health Corp (NYSE: CVS) Trading Performance Indicators
Take a look at CVS Health Corp’s (CVS) current performance indicators. Last quarter, stock had a quick ratio of 0.63. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.25. Likewise, its price to free cash flow for the trailing twelve months is 8.44.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 6.47, a number that is poised to hit 1.71 in the next quarter and is forecasted to reach 9.17 in one year’s time.
Technical Analysis of CVS Health Corp (CVS)
Compared to the last year’s volume of 10.85 million, its volume of 8.57 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 18.56%. Additionally, its Average True Range was 1.69.
During the past 100 days, CVS Health Corp’s (CVS) raw stochastic average was set at 18.38%, which indicates a significant decrease from 24.49% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 34.16% in the past 14 days, which was higher than the 24.61% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $75.18, while its 200-day Moving Average is $72.74. Nevertheless, the first resistance level for the watch stands at $70.19 in the near term. At $70.64, the stock is likely to face the second major resistance level. The third major resistance level sits at $71.34. If the price goes on to break the first support level at $69.05, it is likely to go to the next support level at $68.35. Should the price break the second support level, the third support level stands at $67.90.
CVS Health Corp (NYSE: CVS) Key Stats
The company with the Market Capitalisation of 87.78 billion has total of 1,260,480K Shares Outstanding. Its annual sales at the moment are 357,776 M in contrast with the sum of 8,344 M annual income. Company’s last quarter sales were recorded 93,813 M and last quarter income was 2,046 M.
